List view / Grid view

Financial Results



Regulatory non-compliance business interruptions

29 October 2019 | By

Loss of manufacturing capability as a result of regulatory non-compliance can have a devastating impact on biopharma or medical device manufacturers. In this article, Jenny Yu shares real-life examples from the industry and highlights the downstream effects of these business interruptions.


Successful business year 2014: Sartorius achieves sales and earnings targets – positive outlook for 2015

28 January 2015 | By

Sartorius, a leading international laboratory and pharmaceutical equipment supplier, successfully closed fiscal 2014 according to its preliminary figures, and even slightly exceeded its sales revenue and earnings targets. In addition, the Group is set to further sharpen its strategic profile based on the sale of its smallest division, Industrial Technologies,…